Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban

MeSH terms

• Antibodies, Antiphospholipid / adverse effects*
• Antibodies, Antiphospholipid / immunology*
• Anticoagulants / administration & dosage
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use*
• Humans
• Recurrence
• Rivaroxaban / administration & dosage
• Rivaroxaban / adverse effects
• Rivaroxaban / therapeutic use*
• Thrombosis / blood
• Thrombosis / diagnosis
• Thrombosis / drug therapy*
• Thrombosis / etiology*
• Treatment Outcome
• Vitamin K / antagonists & inhibitors*